Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques

NCT07107971 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Atheroscleroses
Cardiovascular Disease
Vulnerable Coronary Plaques
Vulnerable Plaque
Lipid-Rich Atherosclerosis of Coronary Artery
Acute Coronary Syndromes (ACS)

Interventions

DEVICE: Paclitaxel-eluting balloon

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)